menu
    • menu

    Company profile for Senhwa Biosciences

    NEW Drugs in Dev: 3
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Senhwa Biosciences Inc. was established in 2012 and aims to transform the model for new drug development by focusing on human efficacy. Senhwa believes that its dedication to science and rigorous processes will make Senhwa achieve a remarkable milestone. Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in San Di...
    Senhwa Biosciences Inc. was established in 2012 and aims to transform the model for new drug development by focusing on human efficacy. Senhwa believes that its dedication to science and rigorous processes will make Senhwa achieve a remarkable milestone. Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in San Diego, California, the Senhwa Team is well positioned to oversee the development of their compounds by collaborating with a diverse range of global investigators and service providers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Senhwa BiosciencesTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    10F, No. 225, Sec. 3, Peihsin Rd., Hsintien Dist., New Taipei City 23143
    Telephone
    Telephone
    +886-2-8911-9856
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.senhwabiosciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/senhwa-biosciences
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/senhwabio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Senhwa Launches Global Study of CX-5461 + Tislelizumab
    Senhwa Launches Global Study of CX-5461 + Tislelizumab

    05 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-launches-global-study-targeting-breakthrough-in-hard-to-treat-cancers-with-cx-5461-and-tislelizumab-combination-302762396.html

    PR NEWSWIRE
    05 May 2026
    Share Share
    Senhwa Biosciences Gains Nt$500M Investment From Global Investor
    Senhwa Biosciences Gains Nt$500M Investment From Global Investor

    14 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-secures-strategic-backing-from-global-investor-gem-with-up-to-nt500-million-to-accelerate-ai-driven-drug-development-302741440.html

    PR NEWSWIRE
    14 Apr 2026
    Share Share
    Senhwa Biosciences Introduces CX-5461 For Photodynamic Therapy
    Senhwa Biosciences Introduces CX-5461 For Photodynamic Therapy

    18 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/breakthrough-at-2026-aacr-senhwa-biosciences-cx-5461-enters-the-field-of-photodynamic-therapy-opening-a-new-indication-strategy-302716051.html

    PR NEWSWIRE
    18 Mar 2026
    Share Share
    Senhwa Biosciences Showcases Ai-Validated Oncology Platform
    Senhwa Biosciences Showcases Ai-Validated Oncology Platform

    23 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-highlights-ai-validated-oncology-platform-and-strategic-clinical-collaborations-targeting-next-generation-immuno-oncology-products-at-its-2025-annual-investor-conference-302648612.html

    PR NEWSWIRE
    23 Dec 2025
    Share Share
    Senhwa & BeOne Medicines Ink Deal Targeting Cold Tumors
    Senhwa & BeOne Medicines Ink Deal Targeting Cold Tumors

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-and-beone-medicines-announces-a-clinical-supply-agreement-to-address-the-challenge-of-cold-tumors-302638027.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Senhwa Biosciences' Pidnarulex Partners with Global PD-1 Leaders
    Senhwa Biosciences' Pidnarulex Partners with Global PD-1 Leaders

    16 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/senhwa-biosciences-pidnarulex-joins-forces-with-global-pd-1-leaders-to-advance-next-gen-immunotherapy-17800

    INDPHARMAPOST
    16 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search